We’ve mentioned the 1979 FDA clearance of PEMF bone growth stimulators in a couple of earlier posts. This one is the deeper dive: what the actual research showed, how PEMF is thought to work on bone at a cellular level, and exactly what the clearance does and doesn’t cover.
The problem PEMF was built to solve
Most fractures heal on their own. A small percentage don’t — these are called non-union fractures, where the bone has stopped trying to knit back together, often months after the original injury. Historically, the only real option was additional surgery: bone grafts, hardware, sometimes multiple procedures. Bassett’s research asked whether an external electromagnetic field could restart that stalled healing process without surgery.
Why bone responds to electrical signals at all
Bone tissue is naturally piezoelectric — it generates a small electrical charge when placed under mechanical stress, similar to the quartz crystal we’ve discussed in relation to orgonite. That’s not a coincidence of biology; it’s thought to be part of how bone senses load and knows where to add or remove material over your lifetime. Bassett’s insight was that a stalled fracture site may have lost that natural electrical signaling, and that an external pulsed field could recreate it artificially, prompting the bone to resume remodeling.
At a cellular level, research suggests PEMF stimulates osteoblasts (the cells that build new bone), improves calcium transport across cell membranes, and increases blood vessel formation (angiogenesis) at the injury site — all of which support the raw materials and cellular activity bone needs to heal.
What the results actually showed
A systematic review covering multiple studies on non-union fractures found an average 87% healing rate in bones treated with PEMF — in a population where, by definition, the bone had already failed to heal on its own. Separate research has also shown PEMF can improve bone mineral density in osteoporotic patients, suggesting effects beyond just acute fracture repair.
What the clearance covers — and what it doesn’t
The FDA clearance is specific to: non-union fractures, congenital pseudarthrosis (a birth condition where bone fails to fuse properly), failed spinal fusions, certain fresh high-risk fractures, and as an adjunct to spinal fusion surgery. It’s a narrow, condition-specific medical clearance, not a general endorsement of electromagnetic therapy for wellness, energy, or unrelated pain. We think it’s worth repeating that distinction every time this topic comes up, because marketing language in the wider PEMF industry doesn’t always respect it.
Why we find this one genuinely reassuring
Of everything we’ve written about on this blog, PEMF and bone healing is the closest thing to settled science in the “frequency and the body” conversation. It’s not a reason to assume every frequency-based claim is equally solid — quite the opposite, it’s a useful yardstick for how much stronger real clinical evidence looks compared to the more speculative territory the rest of this blog covers.
Want to explore where frequency and craftsmanship meet?